adamantane has been researched along with sts-135 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Castaneto, M; Gandhi, AS; Huestis, MA; Pang, S; Scheidweiler, KB; Wohlfarth, A; Zhu, M | 1 |
| Banister, SD; Beinat, C; Buchanan, AS; Connor, M; Edington, A; Glass, M; Hibbs, DE; Kassiou, M; Kevin, RC; Longworth, M; McGregor, IS; Stuart, J; Wilkinson, SM | 1 |
| Castelli, MP; Davidson, C; De Luca, MA; Di Chiara, G; Kellett, K; Loi, B; Martorelli, M; Miliano, C; Porcu, A; Schifano, F; Stair, JL | 1 |
| Berg, JD; Ford, LT | 1 |
| Banister, SD; Connor, M; Kassiou, M; Longworth, M | 1 |
| Bush, JM; Fantegrossi, WE; Fujiwara, R; Jones, S; Prather, PL; Radominska-Pandya, A; Yarbrough, AL | 1 |
6 other study(ies) available for adamantane and sts-135
| Article | Year |
|---|---|
High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liv
Topics: Adamantane; Cryopreservation; Designer Drugs; Hepatocytes; Humans; Hydroxylation; Indoles; Metabolic Networks and Pathways; Microsomes, Liver; Oxidation-Reduction | 2015 |
Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.
Topics: Adamantane; Animals; Cannabinoids; Cell Line, Tumor; Designer Drugs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Heart Rate; Humans; Hypothermia; Indoles; Male; Mice; Molecular Structure; Naphthalenes; Quinolines; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Telemetry | 2015 |
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135.
Topics: Adamantane; Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Central Nervous System Stimulants; Dopamine Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Indazoles; Indoles; Male; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Naphthalenes; Nucleus Accumbens; Piperidines; Prefrontal Cortex; Pyrazoles; Quinolines; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1 | 2016 |
1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.
Topics: Adamantane; Adult; Amantadine; Cannabinoids; Chromatography, High Pressure Liquid; Female; Humans; Illicit Drugs; Indazoles; Indoles; Limit of Detection; Male; Substance Abuse Detection; Tandem Mass Spectrometry; United Kingdom | 2016 |
Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA.
Topics: Adamantane; Cannabinoids; Humans; Indazoles; Indoles; Membrane Potentials; Molecular Structure; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2017 |
Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135).
Topics: Adamantane; Brain; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Humans; Indoles; Intestines; Liver; Microsomes; Oxidation-Reduction | 2020 |